View More Recent Stories

Dec 20, 2024 07:01AM Applied Therapeutics Inc. (APLT) Appoints John H. Johnson as Executive Chairman
Dec 19, 2024 06:42AM H.C. Wainwright Reiterates Buy Rating on Verastem (VSTM)
Dec 18, 2024 07:31AM Verastem Oncology (VSTM) Provides a Clinical Update for RAMP 203 Trial
Dec 18, 2024 06:28AM Verastem (VSTM) PT Raised to $9 at Mizuho
Oct 17, 2024 01:40PM Verastem (VSTM) defended at Truist, 'see the weakness as an overreaction and continue to see commercial potential'
Aug 13, 2024 07:13AM Verastem (VSTM) PT Lowered to $15 at Truist Securities
Aug 12, 2024 06:54AM Verastem (VSTM) PT Lowered to $7 at H.C. Wainwright
Aug 8, 2024 06:16PM Verastem Oncology (VSTM) Misses Q2 EPS by 61c
Jul 29, 2024 04:01PM Verastem Oncology (VSTM) Receives FDA Orphan Drug Designation for Avutometinib and Defactinib for the Treatment of Pancreatic Cancer
Jul 29, 2024 07:15AM Verastem (VSTM) PT Lowered to $7 at Mizuho
Jul 24, 2024 07:02AM Verastem (VSTM) PT Lowered to $7 at B.Riley
Jul 23, 2024 04:07PM Verastem Oncology (VSTM) Announces Proposed Share Offering
Jul 8, 2024 11:18AM Verastem (VSTM) PT Lowered to $18 at Truist Securities
View More Recent Stories